EN2: A Potential Drug Target for Neurological Disorders (G2020)

Target Name: EN2

NCBI ID: G2020

Content of Review Report on EN2 Target / Biomarker

EN2

EN2: A Potential Drug Target for Neurological Disorders

EN2, or Engrailed homolog 2, is a protein that is expressed in the brain and is involved in the development and maintenance of neural circuits. It is also involved in the regulation of cell survival and in the progression of certain neurological disorders. As a result of its involvement in these processes, EN2 has been identified as a potential drug target and may be useful in the treatment of certain neurological disorders.

EN2 is a member of the EN family of proteins, which are known for their role in the regulation of neural circuits. This family of proteins includes several different isoforms, including EN1, EN2, EN3, and EN4. EN2 is the most abundant of these isoforms and is expressed in the brain, where it is involved in the development and maintenance of neural circuits.

EN2 is involved in the regulation of several key processes that are critical for the function of neural circuits. For example, it is involved in the regulation of cell survival, which is essential for the formation and maintenance of neural circuits. EN2 also plays a role in the regulation of neurotransmitter release and synaptic plasticity, which are important for the development and maintenance of neural circuits.

In addition to its role in the regulation of neural circuits, EN2 is also involved in the progression of certain neurological disorders. For example, EN2 has been implicated in the development of Alzheimer's disease, a progressive neurodegenerative disorder that is characterized by the progressive loss of brain cells. Studies have shown that EN2 levels are decreased in individuals with Alzheimer's disease and that inhibition of EN2 has been shown to protect against the progression of this disease.

As a result of its involvement in these processes, EN2 has been identified as a potential drug target. Researchers are currently working to develop drugs that can inhibit EN2 activity and prevent the progression of neurological disorders. These drugs may be used to treat a variety of conditions, including Alzheimer's disease and other neurological disorders.

In conclusion, EN2 is a protein that is involved in the development and maintenance of neural circuits and is also involved in the regulation of cell survival and the progression of certain neurological disorders. As a result of its involvement in these processes, EN2 has been identified as a potential drug target and may be useful in the treatment of certain neurological disorders. Further research is needed to fully understand the role of EN2 in neural circuits and to develop effective drugs that can inhibit its activity.

Protein Name: Engrailed Homeobox 2

The "EN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets